US 8772288
Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors
granted A61PA61P1/00A61P11/00
Quick answer
US patent 8772288 (Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors) held by Almirall, S.A. expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P17/06, A61P19/10